Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
04/12/2000 | EP0991946A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
04/12/2000 | EP0991945A2 Method for identification of tumor antigens with autoantibodies in serum |
04/12/2000 | EP0991770A2 Prostate cancer gene |
04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
04/12/2000 | EP0991758A1 Smad6 and uses thereof |
04/12/2000 | EP0991757A1 Novel tumor antigens |
04/12/2000 | EP0991667A1 Antibodies to cryptosporidium |
04/12/2000 | EP0991662A1 Chlamyidia trachomatis specific peptides and their use in diagnostic assays |
04/12/2000 | EP0991423A1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
04/12/2000 | EP0991321A1 Tolerance to natural antibody antigens |
04/12/2000 | EP0766825A4 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
04/12/2000 | EP0676052B1 Detection of cystic fibrosis or a cftr gene mutation |
04/12/2000 | EP0642666B1 Hepatitis c assay |
04/12/2000 | CN1250484A Diagnosis and treatment of glaucoma |
04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
04/12/2000 | CN1250381A Remedies for lymphocytic tumors |
04/12/2000 | CN1250098A Human P47 coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250097A New human gene coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250096A New human protein phosphatase subunit and its coding series and preparation |
04/12/2000 | CN1250095A New human gene series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250094A New human kernon acceptor co-repressor coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250056A Pyloric bacillary spirillum resisting yolk immunoglobulin product and its application |
04/11/2000 | US6048972 Polynucleotide sequences which code for reshaped human monoclonal antibody preferential to interleukins |
04/11/2000 | US6048970 Prostate growth-associated membrane proteins |
04/11/2000 | US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress |
04/11/2000 | US6048966 Preventing blood loss using fibrinogenas a seal; incubation of fibrinogen with splitting enzyme with subseqent application of digested peptides to desired site of action |
04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
04/11/2000 | US6048962 Mammalian protein allergen; for the diagnosis and treatment of mammalian allergic response |
04/11/2000 | US6048837 Dietetics |
04/11/2000 | US6048729 Animal transfected clonal cells for the expression of therapeutic products |
04/11/2000 | US6048717 Enzyme inhibitor that prevents cleavage by immunoglobulin; for treatment of asthma and autoimmune disease |
04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
04/11/2000 | US6048705 Sandwich immunoassays for collagen type I degradation products |
04/11/2000 | US6048704 Microfibrillar protein purified from human tissue which binds vein tissue antibody; for treatment and diagnosis of human vein tissue blockage disease |
04/11/2000 | US6048703 Methods for detecting cell apoptosis |
04/11/2000 | US6048702 Antibody which specifically binds to a oncogene modulating peptide; for the diagnosis and treatment of breast, prostate, or liver cancer; anticarcinogenic agents; antitumor agents |
04/11/2000 | US6048536 Vaccine compositions |
04/11/2000 | US6048528 Monoclonal antibody for diagnostic and therapeutic use in ovarian cancer |
04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
04/11/2000 | US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
04/11/2000 | CA2009946C Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof |
04/06/2000 | WO2000019206A1 Ykl-40 as a marker and prognostic indicator for cancers |
04/06/2000 | WO2000019205A1 Inhibition of pak activation of raf-1 |
04/06/2000 | WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
04/06/2000 | WO2000018923A2 Slgp protein and nucleic acid molecule and uses therefor |
04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
04/06/2000 | WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
04/06/2000 | WO2000018916A2 Human genes and gene expression products |
04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
04/06/2000 | WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
04/06/2000 | WO2000018909A2 NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) |
04/06/2000 | WO2000018895A1 Short peptides which selectively modulate the activity of protein kinases |
04/06/2000 | WO2000018888A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
04/06/2000 | WO2000018806A1 Bispecific and trispecific antibodies which specifically react with inducible surface antigens as operational target structures |
04/06/2000 | WO2000018805A1 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies |
04/06/2000 | WO2000018804A1 Tie2 agonist antibodies |
04/06/2000 | WO2000018803A2 Antibodies to mammalian langerhans cell antigen and their uses |
04/06/2000 | WO2000018801A2 Ncam binding compounds |
04/06/2000 | WO2000018799A1 Artemin, a novel neurotrophic factor |
04/06/2000 | WO2000018797A1 Map |
04/06/2000 | WO2000018796A2 Secretory protein- zsig48 |
04/06/2000 | WO2000018795A2 Compositions and methods for wt1 specific immunotherapy |
04/06/2000 | WO2000018782A2 Hrpca 9 and hrpca 10 nucleic acids and polypeptides |
04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
04/06/2000 | WO2000018436A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
04/06/2000 | WO2000018435A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
04/06/2000 | WO2000018428A2 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor |
04/06/2000 | WO2000018414A1 Transplantation of neural cells for the treatment of ischemic damage due to stroke |
04/06/2000 | WO2000018409A1 Use of certain drugs for treating nerve root injury |
04/06/2000 | WO2000018351A2 Aglyco products and methods of use |
04/06/2000 | WO2000018336A1 Targeted therapy to a biomedical device |
04/06/2000 | WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
04/06/2000 | WO1999067384A3 Prostate cancer-associated genes |
04/06/2000 | WO1999064596A3 Proteins regulating gene expression |
04/06/2000 | WO1999064584A3 Protein for regulating apoptosis |
04/06/2000 | WO1999062941A3 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
04/06/2000 | WO1999061626A3 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
04/06/2000 | WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
04/06/2000 | WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein |
04/06/2000 | WO1999061453A3 priA |
04/06/2000 | WO1999061057A3 Molecules targeting cd40 and tumor cells |
04/06/2000 | WO1999059608A3 Osteoporosis treatment |
04/06/2000 | WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
04/06/2000 | WO1999057144A3 Human transcriptional regulator molecules |
04/06/2000 | WO1999053051A3 5' ests and encoded human proteins |
04/06/2000 | WO1999053042A3 Biological material with increased expression of endogenous complement regulatory molecules |
04/06/2000 | WO1999038972A8 Human genes and gene expression products ii |
04/06/2000 | WO1998050549A3 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr |
04/06/2000 | WO1996013594A8 Tumor-specific antibody fragments, fusion proteins, and uses thereof |
04/06/2000 | CA2714449A1 Use of certain drugs for treating nerve root injury |
04/06/2000 | CA2344766A1 Antibodies to mammalian langerhans cell antigen and their uses |
04/06/2000 | CA2344742A1 Nucleic acids and proteins from cenarchaeum symbiosum |
04/06/2000 | CA2344714A1 Hrpca 9 and hrpca 10 nucleic acids and polypeptides |
04/06/2000 | CA2344712A1 Secretory protein- zsig48 |
04/06/2000 | CA2344658A1 Human kinesin-like motor protein |